Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitamins | 34 | 2024 | 1635 | 4.080 |
Why?
|
Dietary Supplements | 44 | 2024 | 3415 | 3.140 |
Why?
|
Cacao | 11 | 2024 | 98 | 3.110 |
Why?
|
Hypertension | 45 | 2024 | 8540 | 2.930 |
Why?
|
Cardiovascular Diseases | 64 | 2023 | 15500 | 2.550 |
Why?
|
Carotenoids | 12 | 2014 | 621 | 2.370 |
Why?
|
Vitamin D | 17 | 2024 | 3303 | 1.760 |
Why?
|
Blood Pressure | 29 | 2024 | 8481 | 1.700 |
Why?
|
Body Mass Index | 58 | 2021 | 12953 | 1.410 |
Why?
|
Testicular Neoplasms | 13 | 2024 | 799 | 1.380 |
Why?
|
C-Reactive Protein | 17 | 2023 | 3826 | 1.290 |
Why?
|
Risk Factors | 166 | 2024 | 74206 | 1.280 |
Why?
|
Flavonoids | 5 | 2021 | 445 | 1.250 |
Why?
|
Pancreatic Neoplasms | 29 | 2023 | 5368 | 1.240 |
Why?
|
Diet | 24 | 2024 | 8075 | 1.200 |
Why?
|
Overweight | 12 | 2020 | 2417 | 1.200 |
Why?
|
Prospective Studies | 135 | 2024 | 54425 | 1.190 |
Why?
|
Alcohol Drinking | 21 | 2019 | 4028 | 1.160 |
Why?
|
Calcium, Dietary | 5 | 2016 | 529 | 1.120 |
Why?
|
Middle Aged | 253 | 2024 | 220895 | 1.100 |
Why?
|
Motor Activity | 14 | 2015 | 2715 | 1.100 |
Why?
|
Aged | 216 | 2024 | 169289 | 1.030 |
Why?
|
Fatty Acids, Omega-3 | 9 | 2023 | 1390 | 1.000 |
Why?
|
Prostatic Neoplasms | 44 | 2022 | 11118 | 1.000 |
Why?
|
Antioxidants | 11 | 2014 | 1668 | 0.980 |
Why?
|
Proportional Hazards Models | 55 | 2024 | 12463 | 0.970 |
Why?
|
Double-Blind Method | 38 | 2024 | 12341 | 0.940 |
Why?
|
Feeding Behavior | 12 | 2019 | 3188 | 0.930 |
Why?
|
Vitamin E | 10 | 2022 | 872 | 0.930 |
Why?
|
Obesity | 29 | 2024 | 12947 | 0.920 |
Why?
|
Dairy Products | 6 | 2017 | 490 | 0.920 |
Why?
|
Smoking | 33 | 2021 | 9053 | 0.880 |
Why?
|
beta Carotene | 14 | 2023 | 523 | 0.880 |
Why?
|
Weight Gain | 9 | 2020 | 2348 | 0.870 |
Why?
|
Women's Health | 8 | 2016 | 2065 | 0.870 |
Why?
|
Physicians | 25 | 2022 | 4591 | 0.840 |
Why?
|
Renin | 1 | 2024 | 641 | 0.810 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2020 | 550 | 0.810 |
Why?
|
Vitamin D Deficiency | 5 | 2024 | 1388 | 0.810 |
Why?
|
Ascorbic Acid | 7 | 2022 | 655 | 0.800 |
Why?
|
Case-Control Studies | 69 | 2024 | 22176 | 0.800 |
Why?
|
Cause of Death | 17 | 2018 | 3683 | 0.800 |
Why?
|
Polymorphism, Single Nucleotide | 39 | 2023 | 15936 | 0.800 |
Why?
|
Fruit | 6 | 2017 | 1160 | 0.800 |
Why?
|
Humans | 352 | 2024 | 761504 | 0.790 |
Why?
|
Male | 254 | 2024 | 360804 | 0.790 |
Why?
|
Aspirin | 19 | 2024 | 3133 | 0.770 |
Why?
|
Stroke | 17 | 2022 | 9757 | 0.770 |
Why?
|
Life Style | 17 | 2022 | 3917 | 0.750 |
Why?
|
Follow-Up Studies | 71 | 2024 | 39106 | 0.740 |
Why?
|
Neoplasms | 27 | 2023 | 22170 | 0.730 |
Why?
|
Cholecalciferol | 7 | 2024 | 553 | 0.730 |
Why?
|
Cataract | 3 | 2024 | 832 | 0.720 |
Why?
|
Diabetes Mellitus, Type 2 | 22 | 2024 | 12148 | 0.720 |
Why?
|
Exercise | 24 | 2024 | 5890 | 0.720 |
Why?
|
Renin-Angiotensin System | 1 | 2024 | 737 | 0.690 |
Why?
|
Randomized Controlled Trials as Topic | 37 | 2024 | 10209 | 0.680 |
Why?
|
Myocardial Infarction | 19 | 2022 | 11460 | 0.680 |
Why?
|
Fatty Acids, Omega-6 | 3 | 2020 | 225 | 0.670 |
Why?
|
Inflammation | 16 | 2024 | 10773 | 0.660 |
Why?
|
Fishes | 3 | 2019 | 603 | 0.660 |
Why?
|
Incidence | 49 | 2024 | 21353 | 0.650 |
Why?
|
Cohort Studies | 71 | 2024 | 41487 | 0.630 |
Why?
|
Hearing Loss | 6 | 2024 | 783 | 0.630 |
Why?
|
Parathyroid Hormone | 2 | 2024 | 1803 | 0.630 |
Why?
|
Multivariate Analysis | 29 | 2020 | 12059 | 0.620 |
Why?
|
Female | 178 | 2024 | 392644 | 0.620 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 336 | 0.620 |
Why?
|
Food Analysis | 2 | 2012 | 103 | 0.620 |
Why?
|
Risk | 36 | 2015 | 9610 | 0.620 |
Why?
|
Coronary Disease | 19 | 2012 | 5914 | 0.610 |
Why?
|
Cholangiocarcinoma | 6 | 2020 | 552 | 0.610 |
Why?
|
Bile Duct Neoplasms | 6 | 2019 | 605 | 0.610 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2018 | 241 | 0.590 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2016 | 1126 | 0.570 |
Why?
|
Fatty Acids, Monounsaturated | 4 | 2016 | 190 | 0.570 |
Why?
|
Cisplatin | 9 | 2024 | 1651 | 0.560 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 131 | 0.550 |
Why?
|
Vegetables | 6 | 2017 | 1195 | 0.550 |
Why?
|
Risk Assessment | 42 | 2021 | 23995 | 0.550 |
Why?
|
Inflammation Mediators | 2 | 2015 | 1886 | 0.550 |
Why?
|
Health Behavior | 6 | 2019 | 2643 | 0.550 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 174 | 0.540 |
Why?
|
United States | 77 | 2024 | 72334 | 0.540 |
Why?
|
Avitaminosis | 1 | 2016 | 35 | 0.540 |
Why?
|
Nutritional Status | 5 | 2022 | 1615 | 0.530 |
Why?
|
Liver Neoplasms | 10 | 2023 | 4320 | 0.510 |
Why?
|
Calcium | 4 | 2015 | 5722 | 0.500 |
Why?
|
Gout | 1 | 2022 | 621 | 0.490 |
Why?
|
Tinnitus | 4 | 2023 | 196 | 0.490 |
Why?
|
Waist Circumference | 8 | 2021 | 935 | 0.480 |
Why?
|
Odds Ratio | 29 | 2019 | 9646 | 0.480 |
Why?
|
Adult | 131 | 2024 | 221177 | 0.480 |
Why?
|
alpha-Tocopherol | 6 | 2019 | 126 | 0.480 |
Why?
|
Aged, 80 and over | 72 | 2024 | 58976 | 0.480 |
Why?
|
Postmenopause | 7 | 2020 | 2513 | 0.470 |
Why?
|
Physical Fitness | 7 | 2004 | 743 | 0.460 |
Why?
|
Mortality | 8 | 2014 | 2901 | 0.450 |
Why?
|
Dietary Fats | 5 | 2015 | 1995 | 0.450 |
Why?
|
Erythrocytes | 2 | 2015 | 2413 | 0.450 |
Why?
|
Genetic Predisposition to Disease | 26 | 2023 | 17904 | 0.440 |
Why?
|
Dementia | 3 | 2023 | 2686 | 0.440 |
Why?
|
Adiponectin | 4 | 2023 | 1113 | 0.440 |
Why?
|
Carcinoma, Pancreatic Ductal | 7 | 2021 | 1727 | 0.430 |
Why?
|
Central Nervous System Depressants | 1 | 2014 | 164 | 0.430 |
Why?
|
Interleukin-6 | 7 | 2020 | 3208 | 0.430 |
Why?
|
Breast Neoplasms, Male | 4 | 2015 | 219 | 0.420 |
Why?
|
Kynurenine | 4 | 2023 | 141 | 0.420 |
Why?
|
Cholesterol, HDL | 13 | 2016 | 1814 | 0.420 |
Why?
|
Lipids | 8 | 2019 | 3341 | 0.420 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 5 | 2024 | 491 | 0.420 |
Why?
|
Fibrinogen | 1 | 2016 | 888 | 0.410 |
Why?
|
Ethanol | 2 | 2014 | 1324 | 0.410 |
Why?
|
Plant Extracts | 5 | 2023 | 498 | 0.400 |
Why?
|
Tea | 4 | 2005 | 288 | 0.400 |
Why?
|
Genome-Wide Association Study | 22 | 2023 | 12690 | 0.390 |
Why?
|
Cognition | 9 | 2024 | 6990 | 0.390 |
Why?
|
Sex Factors | 16 | 2024 | 10552 | 0.390 |
Why?
|
Receptors, Calcitriol | 2 | 2016 | 360 | 0.380 |
Why?
|
Fragaria | 2 | 2008 | 21 | 0.370 |
Why?
|
Testosterone | 2 | 2020 | 2472 | 0.370 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2011 | 540 | 0.370 |
Why?
|
Congenital Abnormalities | 1 | 2016 | 709 | 0.370 |
Why?
|
Vitamin A | 4 | 2017 | 613 | 0.370 |
Why?
|
Carcinoma, Hepatocellular | 6 | 2020 | 2298 | 0.360 |
Why?
|
Aging | 7 | 2015 | 8708 | 0.350 |
Why?
|
Carcinoma, Large Cell | 3 | 2019 | 113 | 0.350 |
Why?
|
Walking | 7 | 2009 | 1198 | 0.340 |
Why?
|
Coffee | 3 | 2020 | 593 | 0.340 |
Why?
|
Survivors | 5 | 2024 | 2371 | 0.330 |
Why?
|
Diastole | 4 | 2018 | 782 | 0.330 |
Why?
|
Energy Intake | 7 | 2016 | 2134 | 0.320 |
Why?
|
Antibodies, Bacterial | 3 | 2021 | 1469 | 0.320 |
Why?
|
Colorectal Neoplasms | 10 | 2021 | 6935 | 0.320 |
Why?
|
Lung Neoplasms | 14 | 2023 | 13380 | 0.320 |
Why?
|
Gonadal Steroid Hormones | 3 | 2020 | 702 | 0.310 |
Why?
|
Anticarcinogenic Agents | 2 | 2012 | 250 | 0.310 |
Why?
|
Mendelian Randomization Analysis | 5 | 2023 | 1007 | 0.310 |
Why?
|
Systole | 4 | 2018 | 936 | 0.310 |
Why?
|
Hypercholesterolemia | 4 | 2023 | 1141 | 0.310 |
Why?
|
Health Promotion | 5 | 2022 | 2214 | 0.310 |
Why?
|
Poultry | 1 | 2008 | 80 | 0.300 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 7 | 2024 | 2273 | 0.290 |
Why?
|
Helicobacter pylori | 2 | 2023 | 377 | 0.290 |
Why?
|
Neuralgia | 2 | 2024 | 615 | 0.290 |
Why?
|
Helicobacter Infections | 2 | 2023 | 388 | 0.290 |
Why?
|
Health | 1 | 2010 | 398 | 0.290 |
Why?
|
Vitamin B 6 | 3 | 2018 | 234 | 0.280 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2017 | 1228 | 0.280 |
Why?
|
Telomerase | 4 | 2016 | 745 | 0.280 |
Why?
|
Diabetes Mellitus | 7 | 2024 | 5840 | 0.280 |
Why?
|
Food Handling | 1 | 2007 | 154 | 0.280 |
Why?
|
Minerals | 4 | 2024 | 283 | 0.280 |
Why?
|
Gallbladder Neoplasms | 2 | 2019 | 189 | 0.270 |
Why?
|
Endothelium, Vascular | 4 | 2015 | 4431 | 0.270 |
Why?
|
Cholesterol | 10 | 2016 | 2904 | 0.270 |
Why?
|
Contraceptives, Oral, Hormonal | 2 | 2020 | 190 | 0.270 |
Why?
|
Linear Models | 5 | 2018 | 5871 | 0.260 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1277 | 0.260 |
Why?
|
Chromosomes, Human, Pair 5 | 3 | 2016 | 386 | 0.260 |
Why?
|
Anthropometry | 5 | 2019 | 1349 | 0.260 |
Why?
|
Carbon | 2 | 2021 | 666 | 0.260 |
Why?
|
Oncogene Proteins, Fusion | 5 | 2022 | 1606 | 0.250 |
Why?
|
Adenocarcinoma | 8 | 2021 | 6346 | 0.250 |
Why?
|
Body Weight | 7 | 2015 | 4618 | 0.250 |
Why?
|
Serine Endopeptidases | 3 | 2016 | 1022 | 0.250 |
Why?
|
Age Factors | 16 | 2022 | 18395 | 0.250 |
Why?
|
Meat | 1 | 2008 | 584 | 0.240 |
Why?
|
Men's Health | 2 | 2017 | 73 | 0.240 |
Why?
|
Logistic Models | 19 | 2024 | 13255 | 0.240 |
Why?
|
Genotype | 19 | 2021 | 12990 | 0.240 |
Why?
|
Polymorphism, Genetic | 2 | 2012 | 4243 | 0.230 |
Why?
|
Solanum tuberosum | 1 | 2024 | 46 | 0.230 |
Why?
|
Disease Progression | 18 | 2021 | 13506 | 0.230 |
Why?
|
Confidence Intervals | 9 | 2019 | 2927 | 0.230 |
Why?
|
Adiposity | 5 | 2019 | 1878 | 0.230 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2019 | 423 | 0.230 |
Why?
|
Breast Neoplasms | 6 | 2022 | 21012 | 0.230 |
Why?
|
Anthocyanins | 1 | 2024 | 80 | 0.230 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2021 | 8547 | 0.230 |
Why?
|
Bile Ducts, Intrahepatic | 4 | 2020 | 296 | 0.220 |
Why?
|
Cotinine | 3 | 2018 | 206 | 0.220 |
Why?
|
Trace Elements | 2 | 2016 | 195 | 0.220 |
Why?
|
Environment | 1 | 2009 | 1123 | 0.220 |
Why?
|
Fatty Acids | 3 | 2016 | 1808 | 0.220 |
Why?
|
Diabetic Nephropathies | 2 | 2022 | 973 | 0.210 |
Why?
|
Prostate-Specific Antigen | 6 | 2016 | 2469 | 0.210 |
Why?
|
Homocysteine | 1 | 2006 | 638 | 0.210 |
Why?
|
Body Size | 2 | 2017 | 463 | 0.210 |
Why?
|
Cardiotonic Agents | 1 | 2006 | 539 | 0.210 |
Why?
|
Chronic Disease | 4 | 2023 | 9318 | 0.210 |
Why?
|
Life Expectancy | 2 | 2014 | 1242 | 0.210 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26125 | 0.200 |
Why?
|
Leptin | 2 | 2023 | 1597 | 0.200 |
Why?
|
Risk Reduction Behavior | 5 | 2020 | 1112 | 0.200 |
Why?
|
Health Surveys | 7 | 2019 | 4061 | 0.200 |
Why?
|
Time Factors | 20 | 2021 | 39967 | 0.200 |
Why?
|
Glomerular Filtration Rate | 4 | 2024 | 2176 | 0.200 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2016 | 344 | 0.200 |
Why?
|
Migraine Disorders | 3 | 2023 | 1701 | 0.190 |
Why?
|
Seafood | 2 | 2019 | 393 | 0.190 |
Why?
|
Golf | 2 | 2000 | 16 | 0.190 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8599 | 0.190 |
Why?
|
Urban Population | 1 | 2009 | 2036 | 0.190 |
Why?
|
Energy Metabolism | 6 | 2013 | 2882 | 0.190 |
Why?
|
Diet Surveys | 1 | 2005 | 1162 | 0.180 |
Why?
|
Eicosapentaenoic Acid | 3 | 2020 | 561 | 0.180 |
Why?
|
Xanthophylls | 4 | 2012 | 94 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2917 | 0.180 |
Why?
|
Lutein | 4 | 2012 | 123 | 0.180 |
Why?
|
Self Report | 5 | 2022 | 3724 | 0.180 |
Why?
|
Intermediate Filaments | 1 | 2021 | 172 | 0.170 |
Why?
|
Mosaicism | 2 | 2015 | 475 | 0.170 |
Why?
|
Markov Chains | 1 | 2003 | 966 | 0.170 |
Why?
|
Gene Frequency | 3 | 2018 | 3606 | 0.170 |
Why?
|
Receptors, Leptin | 2 | 2023 | 350 | 0.170 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2019 | 4026 | 0.170 |
Why?
|
Genetic Variation | 10 | 2019 | 6567 | 0.170 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2019 | 11742 | 0.170 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2021 | 313 | 0.170 |
Why?
|
Fusobacterium nucleatum | 1 | 2021 | 179 | 0.170 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2017 | 710 | 0.170 |
Why?
|
Fatigue | 2 | 2024 | 1552 | 0.170 |
Why?
|
Receptors, Somatomedin | 1 | 2018 | 56 | 0.160 |
Why?
|
Antineoplastic Agents | 6 | 2024 | 13639 | 0.160 |
Why?
|
Up-Regulation | 4 | 2015 | 4124 | 0.160 |
Why?
|
Carcinoma, Renal Cell | 3 | 2019 | 3164 | 0.160 |
Why?
|
Bacterial Proteins | 4 | 2023 | 3847 | 0.160 |
Why?
|
Estrone | 1 | 2020 | 234 | 0.160 |
Why?
|
Prognosis | 19 | 2022 | 29625 | 0.160 |
Why?
|
Prostate | 3 | 2016 | 1770 | 0.160 |
Why?
|
Hormones | 2 | 2020 | 869 | 0.150 |
Why?
|
Kidney Neoplasms | 4 | 2019 | 4249 | 0.150 |
Why?
|
Health Status | 4 | 2018 | 4077 | 0.150 |
Why?
|
Primary Prevention | 3 | 2019 | 1186 | 0.150 |
Why?
|
Glioma | 4 | 2015 | 3455 | 0.150 |
Why?
|
Nutrigenomics | 1 | 2018 | 24 | 0.150 |
Why?
|
Quantitative Trait Loci | 3 | 2021 | 2116 | 0.150 |
Why?
|
Docosahexaenoic Acids | 3 | 2020 | 908 | 0.150 |
Why?
|
Receptors, Adiponectin | 2 | 2023 | 81 | 0.150 |
Why?
|
Longevity | 3 | 2016 | 1065 | 0.150 |
Why?
|
Mental Disorders | 2 | 2016 | 6845 | 0.150 |
Why?
|
Deficiency Diseases | 1 | 2018 | 74 | 0.150 |
Why?
|
Catechol O-Methyltransferase | 1 | 2019 | 251 | 0.140 |
Why?
|
Biliary Tract Neoplasms | 1 | 2019 | 185 | 0.140 |
Why?
|
Vitamin B 12 | 2 | 2019 | 524 | 0.140 |
Why?
|
Dietary Fiber | 3 | 2015 | 759 | 0.140 |
Why?
|
Genetic Loci | 3 | 2017 | 2632 | 0.140 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 244 | 0.140 |
Why?
|
Squalene Monooxygenase | 1 | 2016 | 11 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 279 | 0.140 |
Why?
|
BRCA1 Protein | 2 | 2016 | 1155 | 0.140 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 420 | 0.130 |
Why?
|
Flavonols | 1 | 2016 | 85 | 0.130 |
Why?
|
Raynaud Disease | 1 | 2017 | 79 | 0.130 |
Why?
|
Uric Acid | 1 | 2022 | 807 | 0.130 |
Why?
|
Tricarboxylic Acids | 1 | 2016 | 26 | 0.130 |
Why?
|
Cholesterol, LDL | 6 | 2016 | 2382 | 0.130 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2016 | 37 | 0.130 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14605 | 0.130 |
Why?
|
Catechin | 1 | 2015 | 69 | 0.130 |
Why?
|
Nonsteroidal Anti-Androgens | 1 | 2015 | 9 | 0.130 |
Why?
|
Hyperlipidemias | 3 | 2012 | 771 | 0.120 |
Why?
|
Receptors, Cytokine | 1 | 2016 | 258 | 0.120 |
Why?
|
Macular Degeneration | 2 | 2013 | 1007 | 0.120 |
Why?
|
Methionine | 1 | 2018 | 572 | 0.120 |
Why?
|
Quercetin | 1 | 2015 | 97 | 0.120 |
Why?
|
Young Adult | 22 | 2021 | 59243 | 0.120 |
Why?
|
Candy | 1 | 2014 | 36 | 0.120 |
Why?
|
Metabolic Diseases | 1 | 2021 | 683 | 0.120 |
Why?
|
Sex Characteristics | 3 | 2022 | 2639 | 0.120 |
Why?
|
Estradiol | 2 | 2020 | 1937 | 0.120 |
Why?
|
Receptor, Insulin | 1 | 2018 | 835 | 0.120 |
Why?
|
Motor Vehicles | 1 | 1997 | 282 | 0.120 |
Why?
|
Vitamin B Complex | 1 | 2017 | 299 | 0.120 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2016 | 452 | 0.120 |
Why?
|
Accidental Falls | 1 | 2023 | 1068 | 0.120 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2016 | 318 | 0.120 |
Why?
|
Leisure Activities | 1 | 2016 | 308 | 0.120 |
Why?
|
Trans-Activators | 2 | 2015 | 2856 | 0.120 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2016 | 638 | 0.120 |
Why?
|
Gastroenteritis | 1 | 2016 | 236 | 0.120 |
Why?
|
Fibrinolysis | 1 | 2015 | 332 | 0.110 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2014 | 87 | 0.110 |
Why?
|
Heart Failure | 5 | 2020 | 11669 | 0.110 |
Why?
|
Leukocytes | 2 | 2019 | 2026 | 0.110 |
Why?
|
Lipoproteins, HDL | 3 | 2019 | 676 | 0.110 |
Why?
|
Trans Fatty Acids | 1 | 2015 | 155 | 0.110 |
Why?
|
China | 4 | 2021 | 2369 | 0.110 |
Why?
|
Alcohol Dehydrogenase | 1 | 2014 | 111 | 0.110 |
Why?
|
Streptococcal Infections | 1 | 2018 | 617 | 0.110 |
Why?
|
Reproductive History | 1 | 2015 | 211 | 0.110 |
Why?
|
Tryptophan | 3 | 2023 | 482 | 0.110 |
Why?
|
Antibody Formation | 1 | 2018 | 1395 | 0.110 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2015 | 422 | 0.110 |
Why?
|
Insulin Resistance | 3 | 2014 | 3963 | 0.110 |
Why?
|
Prostatectomy | 4 | 2014 | 1824 | 0.110 |
Why?
|
Selenoprotein P | 1 | 2012 | 33 | 0.110 |
Why?
|
Iron | 1 | 2021 | 1793 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 840 | 0.100 |
Why?
|
Hypogonadism | 1 | 2019 | 798 | 0.100 |
Why?
|
Survival Analysis | 9 | 2020 | 10090 | 0.100 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 68 | 0.100 |
Why?
|
Neoplasm Staging | 10 | 2019 | 11121 | 0.100 |
Why?
|
Disease | 1 | 2017 | 672 | 0.100 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 374 | 0.100 |
Why?
|
Folic Acid | 2 | 2018 | 1323 | 0.100 |
Why?
|
Waist-Hip Ratio | 3 | 2019 | 518 | 0.100 |
Why?
|
Depression | 2 | 2024 | 8124 | 0.100 |
Why?
|
Adolescent | 20 | 2023 | 88319 | 0.100 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2014 | 269 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1723 | 0.100 |
Why?
|
Models, Cardiovascular | 2 | 2011 | 981 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2018 | 10766 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2735 | 0.100 |
Why?
|
Autoantibodies | 1 | 2020 | 2116 | 0.100 |
Why?
|
Lipogenesis | 1 | 2013 | 214 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2024 | 2046 | 0.100 |
Why?
|
Neopterin | 2 | 2023 | 56 | 0.100 |
Why?
|
Universities | 5 | 2018 | 993 | 0.090 |
Why?
|
Death Certificates | 3 | 2011 | 167 | 0.090 |
Why?
|
Body Height | 3 | 2015 | 1570 | 0.090 |
Why?
|
Boston | 5 | 2011 | 9326 | 0.090 |
Why?
|
Pilot Projects | 2 | 2024 | 8631 | 0.090 |
Why?
|
Placebos | 3 | 2019 | 1667 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 2015 | 1768 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 1934 | 0.090 |
Why?
|
Epidemiologic Methods | 3 | 2019 | 1336 | 0.090 |
Why?
|
Immunohistochemistry | 6 | 2016 | 11076 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1190 | 0.090 |
Why?
|
Counseling | 2 | 2014 | 1547 | 0.090 |
Why?
|
Patient Selection | 1 | 2002 | 4244 | 0.090 |
Why?
|
Eye Diseases | 1 | 2016 | 653 | 0.090 |
Why?
|
Nutrition Surveys | 2 | 2008 | 1733 | 0.090 |
Why?
|
Diet, Fat-Restricted | 2 | 2012 | 329 | 0.090 |
Why?
|
Weight Loss | 2 | 2020 | 2684 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1136 | 0.090 |
Why?
|
Neurotoxicity Syndromes | 1 | 2014 | 301 | 0.090 |
Why?
|
Phenotype | 3 | 2018 | 16591 | 0.090 |
Why?
|
Milk | 1 | 2012 | 443 | 0.090 |
Why?
|
Atherosclerosis | 1 | 2006 | 3408 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1115 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2021 | 5247 | 0.080 |
Why?
|
Metabolomics | 1 | 2019 | 1659 | 0.080 |
Why?
|
Kallikreins | 1 | 2011 | 220 | 0.080 |
Why?
|
Receptors, Fc | 1 | 2013 | 535 | 0.080 |
Why?
|
Selenium | 1 | 2012 | 417 | 0.080 |
Why?
|
Beer | 2 | 2008 | 134 | 0.080 |
Why?
|
Anxiety | 1 | 2024 | 4573 | 0.080 |
Why?
|
Tissue Array Analysis | 3 | 2016 | 550 | 0.080 |
Why?
|
Gene Fusion | 1 | 2012 | 356 | 0.080 |
Why?
|
Wine | 2 | 2008 | 166 | 0.080 |
Why?
|
Heptanoic Acids | 1 | 2011 | 344 | 0.080 |
Why?
|
Population Density | 1 | 2009 | 193 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2928 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2015 | 9420 | 0.080 |
Why?
|
Comorbidity | 8 | 2018 | 10508 | 0.080 |
Why?
|
Kidney | 2 | 2021 | 7048 | 0.080 |
Why?
|
Australia | 3 | 2018 | 1250 | 0.080 |
Why?
|
Alleles | 5 | 2019 | 6863 | 0.080 |
Why?
|
Endoribonucleases | 1 | 2010 | 228 | 0.080 |
Why?
|
Models, Statistical | 2 | 2020 | 5079 | 0.080 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 397 | 0.080 |
Why?
|
Survival Rate | 8 | 2018 | 12725 | 0.080 |
Why?
|
Dyslipidemias | 2 | 2005 | 868 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2015 | 1403 | 0.080 |
Why?
|
Nutrition Policy | 1 | 2012 | 471 | 0.070 |
Why?
|
Internet | 1 | 2000 | 3092 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2020 | 5112 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 579 | 0.070 |
Why?
|
Linkage Disequilibrium | 3 | 2021 | 1998 | 0.070 |
Why?
|
Antihypertensive Agents | 2 | 2015 | 2024 | 0.070 |
Why?
|
Alcoholic Beverages | 2 | 1999 | 264 | 0.070 |
Why?
|
Prevalence | 6 | 2023 | 15732 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 931 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3201 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2014 | 8002 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 916 | 0.070 |
Why?
|
Malus | 2 | 2005 | 50 | 0.070 |
Why?
|
Apolipoprotein A-I | 2 | 2019 | 299 | 0.070 |
Why?
|
Bleomycin | 2 | 2018 | 494 | 0.070 |
Why?
|
Lipoproteins | 1 | 2011 | 881 | 0.070 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 1033 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10723 | 0.070 |
Why?
|
Genes, BRCA1 | 1 | 2010 | 764 | 0.070 |
Why?
|
Animals | 8 | 2019 | 168459 | 0.070 |
Why?
|
Etoposide | 2 | 2018 | 634 | 0.060 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 901 | 0.060 |
Why?
|
Death | 1 | 2010 | 676 | 0.060 |
Why?
|
Asia | 2 | 2018 | 619 | 0.060 |
Why?
|
Bicycling | 1 | 2007 | 177 | 0.060 |
Why?
|
Public Health | 2 | 2014 | 2669 | 0.060 |
Why?
|
Smoking Cessation | 2 | 2021 | 2056 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2422 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2243 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2803 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2011 | 999 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2014 | 3113 | 0.060 |
Why?
|
Databases, Factual | 1 | 2000 | 7967 | 0.060 |
Why?
|
DNA Methylation | 2 | 2016 | 4398 | 0.060 |
Why?
|
Pyrroles | 1 | 2011 | 1125 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2013 | 1376 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6180 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2330 | 0.060 |
Why?
|
Health Personnel | 2 | 2015 | 3335 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13367 | 0.060 |
Why?
|
Age Distribution | 5 | 2011 | 2880 | 0.060 |
Why?
|
Tocopherols | 1 | 2003 | 44 | 0.060 |
Why?
|
Self Disclosure | 1 | 2005 | 249 | 0.060 |
Why?
|
Brassica | 1 | 2003 | 39 | 0.060 |
Why?
|
Audiometry | 1 | 2024 | 253 | 0.060 |
Why?
|
Magnesium | 1 | 2006 | 804 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2022 | 64680 | 0.050 |
Why?
|
Health Services Research | 1 | 2010 | 1812 | 0.050 |
Why?
|
Attitude to Health | 1 | 2012 | 2025 | 0.050 |
Why?
|
Arginine | 1 | 2006 | 934 | 0.050 |
Why?
|
Parkinson Disease | 2 | 2007 | 2877 | 0.050 |
Why?
|
Sex Distribution | 1 | 2008 | 2281 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2332 | 0.050 |
Why?
|
Databases, Genetic | 2 | 2020 | 1742 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2005 | 370 | 0.050 |
Why?
|
Carbonated Beverages | 1 | 2023 | 210 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2021 | 7856 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3617 | 0.050 |
Why?
|
Cattle | 1 | 2008 | 3849 | 0.050 |
Why?
|
Acetaminophen | 2 | 2022 | 554 | 0.050 |
Why?
|
Genome, Human | 1 | 2015 | 4425 | 0.050 |
Why?
|
Coronary Artery Disease | 2 | 2019 | 6403 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2013 | 9031 | 0.050 |
Why?
|
Brain Ischemia | 2 | 2006 | 3049 | 0.050 |
Why?
|
Cyclin T | 1 | 2021 | 19 | 0.050 |
Why?
|
Adipokines | 1 | 2023 | 310 | 0.050 |
Why?
|
Sports | 3 | 2006 | 705 | 0.050 |
Why?
|
Europe | 3 | 2018 | 3422 | 0.050 |
Why?
|
Triglycerides | 4 | 2016 | 2461 | 0.050 |
Why?
|
Menopause | 2 | 2020 | 1646 | 0.050 |
Why?
|
Meta-Analysis as Topic | 2 | 2016 | 1380 | 0.050 |
Why?
|
Dietary Sucrose | 1 | 2003 | 243 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2571 | 0.050 |
Why?
|
Body Fat Distribution | 1 | 2022 | 245 | 0.050 |
Why?
|
Sweetening Agents | 1 | 2023 | 290 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2023 | 80636 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2895 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4936 | 0.050 |
Why?
|
Health Services | 1 | 2006 | 752 | 0.050 |
Why?
|
United States Social Security Administration | 1 | 2000 | 11 | 0.050 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.040 |
Why?
|
Molecular Epidemiology | 2 | 2014 | 469 | 0.040 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1858 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2010 | 1797 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5127 | 0.040 |
Why?
|
Computational Biology | 3 | 2019 | 3518 | 0.040 |
Why?
|
Predictive Value of Tests | 6 | 2016 | 15266 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6484 | 0.040 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 49 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3579 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2013 | 3979 | 0.040 |
Why?
|
Medical Records | 1 | 2005 | 1408 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5315 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14666 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 2020 | 168 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2019 | 120 | 0.040 |
Why?
|
Ampulla of Vater | 1 | 2019 | 149 | 0.040 |
Why?
|
Genetic Markers | 2 | 2019 | 2601 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2091 | 0.040 |
Why?
|
Subcutaneous Fat | 1 | 2022 | 393 | 0.040 |
Why?
|
Bile Ducts | 1 | 2020 | 282 | 0.040 |
Why?
|
MMPI | 1 | 1998 | 81 | 0.040 |
Why?
|
NAD | 1 | 2023 | 614 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6310 | 0.040 |
Why?
|
Cholangitis, Sclerosing | 1 | 2020 | 177 | 0.040 |
Why?
|
Insulin | 3 | 2019 | 6596 | 0.040 |
Why?
|
Frail Elderly | 1 | 2024 | 765 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7827 | 0.040 |
Why?
|
Visual Acuity | 3 | 2013 | 2672 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 239 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2003 | 891 | 0.040 |
Why?
|
Beverages | 1 | 2023 | 821 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2018 | 92 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2018 | 126 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2012 | 12795 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1155 | 0.040 |
Why?
|
Pancreatitis, Chronic | 1 | 2020 | 289 | 0.040 |
Why?
|
Intra-Abdominal Fat | 1 | 2022 | 613 | 0.040 |
Why?
|
Speech Reception Threshold Test | 1 | 2016 | 16 | 0.030 |
Why?
|
Receptor, IGF Type 1 | 1 | 2018 | 379 | 0.030 |
Why?
|
Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
Family Health | 1 | 2001 | 1257 | 0.030 |
Why?
|
Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
Signal Transduction | 2 | 2018 | 23445 | 0.030 |
Why?
|
Massachusetts | 4 | 2011 | 8830 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5146 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3245 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 582 | 0.030 |
Why?
|
Adenoma | 1 | 2006 | 2160 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 1 | 2016 | 210 | 0.030 |
Why?
|
Educational Status | 1 | 2003 | 2522 | 0.030 |
Why?
|
Apolipoprotein B-100 | 1 | 2016 | 157 | 0.030 |
Why?
|
Cooperative Behavior | 2 | 2013 | 1505 | 0.030 |
Why?
|
Phlebotomy | 1 | 2016 | 137 | 0.030 |
Why?
|
Meat Products | 1 | 2015 | 96 | 0.030 |
Why?
|
European Union | 1 | 2016 | 157 | 0.030 |
Why?
|
Hearing Loss, Conductive | 1 | 2016 | 159 | 0.030 |
Why?
|
Kidney Calculi | 1 | 2019 | 463 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 999 | 0.030 |
Why?
|
Drug Combinations | 2 | 2012 | 2048 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7581 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2006 | 2656 | 0.030 |
Why?
|
Phospholipids | 1 | 1999 | 786 | 0.030 |
Why?
|
Executive Function | 1 | 2023 | 1389 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 857 | 0.030 |
Why?
|
Liver Diseases | 1 | 2023 | 1298 | 0.030 |
Why?
|
Auditory Threshold | 1 | 2016 | 369 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1303 | 0.030 |
Why?
|
Disabled Persons | 1 | 2024 | 1225 | 0.030 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2016 | 144 | 0.030 |
Why?
|
Albuminuria | 1 | 2018 | 657 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 783 | 0.030 |
Why?
|
Trypsin Inhibitor, Kazal Pancreatic | 1 | 2014 | 30 | 0.030 |
Why?
|
Blood Glucose | 3 | 2019 | 6391 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3162 | 0.030 |
Why?
|
Drinking | 1 | 2015 | 198 | 0.030 |
Why?
|
Orchitis | 1 | 2014 | 35 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2015 | 205 | 0.030 |
Why?
|
Epididymitis | 1 | 2014 | 37 | 0.030 |
Why?
|
Food | 1 | 2019 | 774 | 0.030 |
Why?
|
Klinefelter Syndrome | 1 | 2014 | 47 | 0.030 |
Why?
|
Habits | 1 | 2014 | 147 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2014 | 371 | 0.030 |
Why?
|
Catalase | 1 | 2014 | 218 | 0.030 |
Why?
|
Morbidity | 1 | 1999 | 1750 | 0.030 |
Why?
|
Gynecomastia | 1 | 2014 | 87 | 0.030 |
Why?
|
Laboratories | 1 | 2017 | 458 | 0.030 |
Why?
|
Proinsulin | 1 | 2013 | 135 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 943 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1935 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 384 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15842 | 0.030 |
Why?
|
Glutathione Peroxidase | 1 | 2014 | 258 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 70 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4915 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2016 | 600 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1116 | 0.030 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2015 | 410 | 0.030 |
Why?
|
Celiac Disease | 1 | 2020 | 821 | 0.020 |
Why?
|
Area Under Curve | 1 | 2016 | 1638 | 0.020 |
Why?
|
Veterans | 1 | 2006 | 2647 | 0.020 |
Why?
|
Diabetes Complications | 1 | 1999 | 1315 | 0.020 |
Why?
|
Physical Examination | 1 | 2018 | 1255 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1612 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2013 | 297 | 0.020 |
Why?
|
Canada | 1 | 2017 | 2122 | 0.020 |
Why?
|
Bone Neoplasms | 2 | 2015 | 2529 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 594 | 0.020 |
Why?
|
Cholesterol, VLDL | 1 | 2011 | 70 | 0.020 |
Why?
|
Sweden | 1 | 2014 | 1379 | 0.020 |
Why?
|
Data Collection | 1 | 2000 | 3322 | 0.020 |
Why?
|
Body Composition | 1 | 2000 | 2426 | 0.020 |
Why?
|
Serotonin | 1 | 2015 | 1041 | 0.020 |
Why?
|
Caffeine | 1 | 2015 | 700 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1651 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 785 | 0.020 |
Why?
|
Testis | 1 | 2014 | 794 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2005 | 7390 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2014 | 9280 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1459 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2015 | 897 | 0.020 |
Why?
|
United Arab Emirates | 1 | 2009 | 42 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2012 | 943 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 17351 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2013 | 368 | 0.020 |
Why?
|
Reproduction | 1 | 2014 | 645 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2011 | 479 | 0.020 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2008 | 45 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2013 | 793 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1541 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 11903 | 0.020 |
Why?
|
Glioblastoma | 2 | 2015 | 3482 | 0.020 |
Why?
|
International Cooperation | 1 | 2015 | 1422 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5073 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1998 | 6019 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 1922 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2010 | 629 | 0.020 |
Why?
|
Medication Adherence | 1 | 2019 | 2176 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3085 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.020 |
Why?
|
Androgens | 1 | 2015 | 1286 | 0.020 |
Why?
|
Crohn Disease | 1 | 2020 | 2279 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1648 | 0.020 |
Why?
|
Thinness | 1 | 2010 | 490 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1125 | 0.020 |
Why?
|
Hemorrhage | 1 | 2019 | 3424 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 851 | 0.020 |
Why?
|
Particle Size | 1 | 2011 | 1648 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2986 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4278 | 0.020 |
Why?
|
Phytotherapy | 1 | 2008 | 296 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1745 | 0.020 |
Why?
|
Algorithms | 2 | 2008 | 14031 | 0.020 |
Why?
|
Cataract Extraction | 1 | 2010 | 467 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7045 | 0.020 |
Why?
|
Nurses | 1 | 2016 | 2478 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2015 | 2161 | 0.020 |
Why?
|
DNA Damage | 1 | 2016 | 2446 | 0.020 |
Why?
|
Recreation | 1 | 2006 | 125 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1405 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2645 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3810 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2012 | 20098 | 0.020 |
Why?
|
Proline | 1 | 2006 | 457 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1640 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3688 | 0.010 |
Why?
|
Lung | 1 | 2022 | 10000 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8529 | 0.010 |
Why?
|
gamma-Tocopherol | 1 | 2003 | 30 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8654 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2223 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10445 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6032 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9486 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3442 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2008 | 2231 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2007 | 970 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3778 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2008 | 966 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2008 | 1725 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3802 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5428 | 0.010 |
Why?
|
Tennis | 1 | 2000 | 21 | 0.010 |
Why?
|
Physical Exertion | 1 | 2003 | 667 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20570 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14414 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2008 | 2188 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8465 | 0.010 |
Why?
|
Patient Compliance | 1 | 2008 | 2690 | 0.010 |
Why?
|
Mutation | 2 | 2015 | 30052 | 0.010 |
Why?
|
Child | 2 | 2019 | 80153 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5821 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2001 | 675 | 0.010 |
Why?
|
Biomedical Research | 1 | 2013 | 3429 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2006 | 2421 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2005 | 6228 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2003 | 1208 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22169 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2477 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18252 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11528 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1999 | 3416 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26198 | 0.010 |
Why?
|
Interviews as Topic | 1 | 1999 | 2696 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36192 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42230 | 0.010 |
Why?
|
Mice | 1 | 2014 | 81525 | 0.000 |
Why?
|
Patient Discharge | 1 | 1999 | 3443 | 0.000 |
Why?
|